Ilika plc
("Ilika" or the "Company")
Directorate Change and Conversion of Securities
Ilika (AIM: IKA), the advanced cleantech materials discovery company, announces a change of Director effective 30 June 2013.
Dr. Werner Braun, who has been a director of Ilika since 24 May 2007, has today agreed with the board that he will step down at the end of his current fixed term in office. Since divesting Ilika's wound care services and products business, Altrika Ltd, in December 2012, the Company is seeking to more closely align the sector experience of the Board with its core business. In due course, the Company will seek to appoint a replacement non-executive director.
Jack Boyer, Ilika's Chairman, said: "On behalf of the Company, I would like to thank Werner for his loyal and diligent service to the Company. Werner's wealth of experience in growing small businesses to substantial enterprises has been of great assistance to the development of Ilika from a University spin-out to a public company."
The company also announces the conversion of 100,000 convertible preference shares into ordinary shares of 1p each, by a founding shareholder. The figure of 48,349,033 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
For more information contact:| Ilika plc | www.ilika.com |
| Graeme Purdy, Chief Executive | Tel: 023 8011 1400 |
| Steve Boydell, Finance Director | |
| Numis Securities Limited | Tel: 020 7260 1000 |
| Oliver Cardigan, Nominated Adviser | |
| James Black, Corporate Broking | |
| Walbrook PR Ltd | Tel: 020 7933 8780 |
| Paul McManus | Mob: 07980 541 893 or ilika@walbrookpr.com |
| Paul Cornelius | Mob: 07827 879 460 or ilika@walbrookpr.com |
This information is provided by RNS